SECAUCUS, N.J., Feb. 22,
2018 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE:
DGX), the world's leading provider of diagnostic information
services, announced that it is scheduled to speak at the Raymond
James 39th Annual Institutional Investors Conference in
Orlando. Mark Guinan, Executive Vice President and CFO
will discuss the company's vision, goals and two-point strategy to
accelerate growth and drive operational excellence. The
presentation is scheduled for Tuesday, March
6, 2018 at 1:05 p.m. Eastern
Time.
The presentation will be webcast live during the conference and
will be available to registered investors on the following site:
http://wsw.com/webcast/rj108/dgx and to the public on the company's
investor relations page which can be accessed at
ir.QuestDiagnostics.com. In addition, the archived webcast
will be available within one hour after the conclusion of the live
event and will remain available until March
13, 2018.
About Quest Diagnostics
Quest
Diagnostics empowers people to take action to improve health
outcomes. Derived from the world's largest database of
clinical lab results, our diagnostic insights reveal new avenues to
identify and treat disease, inspire healthy behaviors and improve
health care management. Quest annually serves one in three adult
Americans and half the physicians and hospitals
in the United States, and our 45,000 employees understand
that, in the right hands and with the right context, our diagnostic
insights can inspire actions that transform
lives. www.QuestDiagnostics.com.
View original content with
multimedia:http://www.prnewswire.com/news-releases/quest-diagnostics-to-speak-at-the-raymond-james-39th-annual-institutional-investors-conference-300603053.html
SOURCE Quest Diagnostics